Aspen Neuroscience, Inc.
Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Aspen Neuroscience develops personalized cell therapies for neurodegenerative diseases, starting with Parkinson's disease, using a patient's own skin cells to create induced pluripotent stem cells that are converted into dopamine-producing neurons for transplantation. The company is based in San Diego, California.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| ARCH Venture Fund X, L.P.10% Owner | Buy | $18.00M | 1,200,000at $15.00 | Nov 2, 2026 |
| ARCH Venture Partners XIV, L.P.10% Owner | Buy | $18.00M | 1,200,000at $15.00 | Nov 2, 2026 |
| ARCH Venture Fund X, L.P.10% Owner | Buy | $1.00M | 66,667at $15.00 | Nov 2, 2026 |
| ARCH Venture Fund X, L.P.10% Owner | Buy | $1000K | 66,666at $15.00 | Nov 2, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable ASPE activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.